ArticleInternational urogynecology journal2025
Anxiety and Depression in Japanese Patients with Genitourinary Syndrome of Menopause.
Article in International urogynecology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introduction and hypothesisWomen with genitourinary syndrome of menopause (GSM) may have anxiety and depression; however, this is unclear.
methodsA total of 646 postmenopausal women undergoing treatment for menopausal symptoms were enrolled in this retrospective cross-sectional study. Questionnaire responses were recorded at the first visit, and participants were divided into GSM (≥1 moderate or severe GSM symptom) or no-GSM (without any moderate/severe symptoms) groups. Mental health was assessed using the Hospital Anxiety and Depression Scale (HADS). The HADS scores of the two groups were compared, and GSM symptoms affecting mental health were analyzed using a logistic regression model.
results350 (54.2%) women were assigned to the GSM group. Among GSM symptoms, urinary frequency was the most common (moderate/severe: 37.5%). The proportion of participants with anxiety was significantly higher in the GSM group than in the no-GSM group, and odds ratio (OR) was 1.429 (95% confidence interval [CI]: 1.046-1.951). Additionally, the proportion of participants with both anxiety and depression was significantly higher in the GSM group than in the no-GSM group. Furthermore, logistic regression analysis showed that urinary frequency was significantly associated with anxiety (OR 1.429; 95% CI 1.046-1.951) and depression (OR 1.639, 95% CI 1.189-2.261).
conclusionsJapanese women with GSM reported higher HADS scores for anxiety than those without GSM. Among GSM symptoms, urinary frequency was common, which affected the mental health of menopausal women the most. Therefore, clinicians should be aware of the possibility that women seeking care for menopausal symptoms may have comorbid frequent urination and anxiety.
Indexed as
Identifiers
39644347What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.